FLGT Q3 2020 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$447M

Q3 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$102M+883.0% YoY

Gross Profit

$75M74.2% margin

Operating Income

$64M62.5% margin

Net Income

$47M45.9% margin

EPS (Diluted)

$1.98

QoQ Revenue Growth

+489.1%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

-$714,000

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$247M

Total Liabilities

$60M

Stockholders' Equity

$187M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$102M	$10M	+883.0%
Gross Profit	$75M	$6M	+1067.7%
Operating Income	$64M	$2M	+4109.6%
Net Income	$47M	$1M	+3090.0%

Geographic Segments

UNITED STATES

$100M99%

Other Countries

$1M1%

CANADA

$376,0000%